MEDTRONIC HEART VALVES DIVISION EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
|
Back to Search Results |
|
Model Number D-EVOLUTFX-2329 |
Device Problem
Device Dislodged or Dislocated (2923)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 04/11/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
Continuation of d10: product id l-evolutfx-2329 (lot: 0011939307); product type: 0195-heart valves section d references the main component of the system.Other medical products in use during the event include: brand name evolut fx valve; product id evolutfx-26 (serial: j117864); product type: 0195-heart valves medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Medtronic received information that during implant of this transcatheter bioprosthetic valve, the valve was recaptured one or two times. during that time, the pacing rate was set to 140bpm, and the speed of turning the handle was as fast as medtronic's recommendation, but the valve would not anchor because there was a little calcification present.As far as the computed tomography (ct) was checked, the left ventricular outflow tract (lvot) was not particularly narrow or flat.The valve leaflets were not thickened, and per the physician, the amount of calcification might be related to the anchoring difficulty.The valve and delivery catheter system (dcs) were removed from the patient, discarded, and replaced with non-medtronic products.No adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Additional information was received indicating that a pre-implant balloon aortic valvuloplasty (bav) was performed.The deployment s tarting point was at the bottom of the pigtail catheter.Prior to dislodgement, the valve was positioned at a depth of 3 millimeter (mm).The valve subsequently dislodged aortic.It was noted that a non-medtronic (safari) guidewire was used during the procedure.
|
|
Search Alerts/Recalls
|
|
|